To mark Breast Cancer Awareness Month, the Jerusalem Municipality and the Hadassah Medical Center will hold an information event at the municipality building auditorium on 18.11.2018 (Sunday), from 9:30 to 12:00. The event is intended for female Jerusalem Municipality employees, and during the day free, anonymous screenings will be conducted by Hadassah doctors.
Jerusalem Municipality Chief of Staff Michal Shalem will open the event. Afterwards, Prof. Tamar Peretz, Director of the Sharett Institute of Oncology at the Hadassah Medical Center, will review the screening process, the importance of early detection and treatment methods. Other experts will present the various perspectives of dealing with the disease – both mental and physical, as well as those which concern the patient, her family and those around her. In addition, the employees will hear the personal story of a patient named Ruth, who was diagnosed, treated and had successful treatment. At the end of the event, a panel of experts will answer audience questions and provide extensive information on the subject.
Jerusalem Municipality Chief of Staff Michal Shalem explained that, "The Jerusalem Municipality attaches great importance to raising awareness of the struggle against breast cancer. Each November in recent years we illuminate the municipality building with pink light in an effort to increase awareness and to cause many women in Jerusalem to get screened and understand that a simple exam could save lives. Thanks to early detection, treatment rates in Jerusalem are the highest in the country, but we must still continue and encourage younger and older women alike to be screened every year. It is our duty and our responsibility."
Stabilization of Morbidity Rates and Low Rates in Jerusalem
Prof. Tamar Peretz noted that the trends in morbidity rates in Israel show that up to five years ago, an increase in the incidence of the disease was observed. However, the trend has changed and rates have now stabilized. Nonetheless, there is an increase in the incidence of the disease and a decline in the morbidity age among women born in the country, both of Jewish and Arab origin.
Morbidity rates in Jerusalem are significantly lower than those in Tel Aviv and Haifa, but there are many young women being treated for breast cancer at the Hadassah Medical Center. At the same time, rates of successful treatment of the disease in Jerusalem are higher than those around the country. Prof. Peretz also emphasized that demographically, patients being treated at Hadassah's Sharett Institute come from all areas of the city and from communities located around Jerusalem. Some 30% of patients come from other parts of the country. In addition, there is also a clinic for healthy women who have a high risk of getting the disease.
"Every woman understands that it is important to diagnose breast cancer early on," said Peretz. "With that, it's clear that there is a certain difficulty in getting screened. We are familiar with the hard-working residents of Jerusalem, and among their many activities, the women of the city can't always find the time to get screened. Therefore, during Breast Cancer Awareness Month, we provide them with access to screening and information. We will arrive at the Jerusalem Municipality from Hadassah as an entire team in order to enable women to hear, to know and to be screened," she concluded.